Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression
British Journal of Haematology · 2024-06 · 204 (6) · 2259-2263
DOI: 10.1111/bjh.19446 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 11.04.2024. Verfasst von Wei-Ying Jen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Antigens, CD7, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, The University of Texas MD Anderson Cancer Center Leukemia SPORE Grant.
Abstract (Originalsprache)
Targeted therapy development for acute myeloid leukaemia (AML) requires an understanding of specific expression profiles. We collected flow cytometry data on 901 AML patients and recorded aberrant CD7 expression on leukaemic blasts. 263 (29.2%) had blasts positive for CD7. CD7+ AML was more likely to be adverse risk (64.6% vs. 55.6%, p = 0.0074) and less likely to be favourable risk (15.2% vs. 24.1%, p = 0.0074) by European LeukemiaNet 2022 criteria. Overall survival was inferior (11.9 [95% CI, 9.7–15.9] vs. 19.0 months [95% CI, 16.1–23.0], p = 0.0174). At relapse, 30.4% lost and 19.0% gained CD7, suggesting moderate instability over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Wei-Ying Jen, Koji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan M Kadia, Ghayas C Issa, Nicholas J Short, Musa Yilmaz, Naval G Daver, Courtney D DiNardo
Förderung
- NCI NIH HHS
- The University of Texas MD Anderson Cancer Center Leukemia SPORE Grant
Zitieren
APA
Jen, W. Y., Sasaki, K., Loghavi, S., Wang, S. A., Qiao, W., Borthakur, G., Ravandi, F., Kadia, T. M., Issa, G. C., Short, N. J., Yilmaz, M., Daver, N. G., & DiNardo, C. D. (2024). Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British Journal of Haematology, 204(6), 2259-2263. https://doi.org/10.1111/bjh.19446
Vancouver
Jen WY, Sasaki K, Loghavi S, Wang SA, Qiao W, Borthakur G, et al. Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British Journal of Haematology. 2024;204(6):2259-2263. doi:10.1111/bjh.19446
BibTeX
@article{Jen2024,
author = {Jen, Wei-Ying and Sasaki, Koji and Loghavi, Sanam and Wang, Sa A and Qiao, Wei and Borthakur, Gautam and Ravandi, Farhad and Kadia, Tapan M and Issa, Ghayas C and Short, Nicholas J and Yilmaz, Musa and Daver, Naval G and DiNardo, Courtney D},
title = {Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression},
journal = {British Journal of Haematology},
year = {2024},
volume = {204},
number = {6},
pages = {2259--2263},
doi = {10.1111/bjh.19446}
}
EUVIMED